Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oct 5, 2010


Signature Diagnostics has named Rainer Kramer as its chief business officer. Kramer formerly was vice president of corporate business development at Jerini, and before that he worked in research and business development at MorphoSys and at Amgen.

Integromics has appointed Michael McManus as its president and CEO.

McManus most recently led GenomeQuest's corporate marketing, strategic alliances, product marketing, and development efforts. He also served as vice president of business development for the BioSciences Group at Fujitsu Computer Systems, executive VP and COO at Anvil Informatics, and VP of marketing and business development at CambridgeSoft.

Asterand has appointed Dalia Cohen to the position of chief scientific officer. Cohen joins Asterand from Rosetta Genomics, where she also served as CSO.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.